{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:43:28Z","timestamp":1788921808499,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Minas Gerais State Foundation of Support to the Research","doi-asserted-by":"publisher","award":["APQ-02344-18"],"award-info":[{"award-number":["APQ-02344-18"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Minas Gerais State Foundation of Support to the Research","doi-asserted-by":"publisher","award":["APQ-01857-21"],"award-info":[{"award-number":["APQ-01857-21"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbrc.2024.150765","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T13:14:00Z","timestamp":1727702040000},"page":"150765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Standard chemotherapy impacts on in vitro cellular heterogeneity in spheroids enriched with cancer stem cells (CSCs) derived from triple-negative breast cancer cell line"],"prefix":"10.1016","volume":"734","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3658-8008","authenticated-orcid":false,"given":"Milene Pereira","family":"Moreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza Pereira","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara Avelar Ferreira","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Rocha dos","family":"Anjos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2723-8784","authenticated-orcid":false,"given":"Daniela de Gouv\u00eaa","family":"Almada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2678-5340","authenticated-orcid":false,"given":"Isabela Nery Tavares","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia da Concei\u00e7\u00e3o","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geovanni Dantas","family":"Cassali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Maria","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"august","key":"10.1016\/j.bbrc.2024.150765_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours. [Letter]","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.bbrc.2024.150765_bib2","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.bbrc.2024.150765_bib3","first-page":"1","article-title":"Clinical implications of molecular heterogeneity in triple negative breast cancer Brian","volume":"24","author":"Lehmann","year":"2015","journal-title":"Breast"},{"issue":"15","key":"10.1016\/j.bbrc.2024.150765_bib4","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150765_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/cncr.28914","article-title":"Subtyping of triple-negative breast cancer: implications for therapy","volume":"121","author":"Abramson","year":"2015","journal-title":"Cancer"},{"issue":"29","key":"10.1016\/j.bbrc.2024.150765_bib6","doi-asserted-by":"crossref","first-page":"26560","DOI":"10.18632\/oncotarget.5306","article-title":"Triple negative breast cancer: looking for the missing link between biology and treatments","volume":"6","author":"Palma","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.bbrc.2024.150765_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157368","article-title":"Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection","volume":"11","author":"Lehmann","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bbrc.2024.150765_bib8","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.bbrc.2024.150765_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122142","article-title":"Tumour heterogeneity: the key advantages of single-cell analysis","volume":"17","author":"Tellez-Gabriel","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150765_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.critrevonc.2017.03.016","article-title":"The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors","volume":"113","author":"Fonseca","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrc.2024.150765_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ctrv.2016.07.001","article-title":"The cancer stem-cell signaling network and resistance to therapy","volume":"49","author":"Carnero","year":"2016","journal-title":"Cancer Treat Rev."},{"issue":"7","key":"10.1016\/j.bbrc.2024.150765_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrd4253","article-title":"Tackling the cancer stem cells \u2013 what challenges do they pose?","volume":"13","author":"Pattabimaran","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2024.150765_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pharmthera.2016.02.008","article-title":"Cancer stem cells and chemoresistance: the smartest survives the raid","volume":"160","author":"Zhao","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.bbrc.2024.150765_bib14","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.bbrc.2024.150765_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.bbrc.2024.150765_bib16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1073\/pnas.1111053108","article-title":"CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer","volume":"109","author":"Zeng","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2024.150765_bib17","first-page":"5506","volume":"vol. 13","author":"Ponti","year":"2005"},{"issue":"3","key":"10.1016\/j.bbrc.2024.150765_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cas.13155","article-title":"Tumor-derived spheroids: relevance to cancer stem cells and clinical applications","volume":"108","author":"Ishiguro","year":"2017","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.bbrc.2024.150765_bib19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.18632\/oncotarget.6261","article-title":"Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bbrc.2024.150765_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","article-title":"Hallmarks of cancer stemness","volume":"31","author":"Loh","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"February","key":"10.1016\/j.bbrc.2024.150765_bib21","first-page":"1","article-title":"The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer","volume":"15","author":"Dou","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbrc.2024.150765_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2018.01.018","article-title":"STAT3 as a promising chemoresistance biomarker associated with the CD44 +\/high\/CD24 -\/low\/ALDH + BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line","volume":"363","author":"Moreira","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"January","key":"10.1016\/j.bbrc.2024.150765_bib23","article-title":"Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer","volume":"52","author":"Ouyang","year":"2022","journal-title":"Redox Biol."},{"issue":"14","key":"10.1016\/j.bbrc.2024.150765_bib24","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bbrc.2024.150765_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06262-5","article-title":"mTOR inhibition suppresses salinomycin-induced ferroptosis in breast cancer stem cells by ironing out mitochondrial dysfunctions","volume":"14","author":"Cosialls","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150765_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-022-05508-y","article-title":"The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity","volume":"9","author":"Zhao","year":"2023","journal-title":"Cell Death Dis."},{"issue":"55","key":"10.1016\/j.bbrc.2024.150765_bib27","first-page":"2","article-title":"Cytotoxic activity of Thai medicinal plants against human cholangiocarcinoma, laryngeal and hepatocarcinoma cells in vitro","volume":"10","author":"Mahavorasirikul","year":"2010","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.bbrc.2024.150765_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep14701","article-title":"An automated fitting procedure and software for dose-response curves with multiphasic features","volume":"5","author":"Di Veroli","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150765_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"9","key":"10.1016\/j.bbrc.2024.150765_bib30","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150765_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-pathol-020712-163923","article-title":"Cellular heterogeneity and molecular evolution in cancer","volume":"8","author":"Almendro","year":"2013","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.bbrc.2024.150765_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","article-title":"Cancer stem cells: current status and evolving complexities","volume":"10","author":"Visvader","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.bbrc.2024.150765_bib33","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1381612821666141211120604","article-title":"Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance","volume":"21","author":"Luo","year":"2015","journal-title":"Curr. Pharmaceut. Des."},{"issue":"33","key":"10.1016\/j.bbrc.2024.150765_bib34","doi-asserted-by":"crossref","first-page":"13820","DOI":"10.1073\/pnas.0905718106","article-title":"Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features","volume":"106","author":"Creighton","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150765_bib35","first-page":"2015","article-title":"Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo","volume":"7","author":"Jia","year":"2015"},{"key":"10.1016\/j.bbrc.2024.150765_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biomaterials.2016.06.038","article-title":"Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells","volume":"103","author":"Sun","year":"2016","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150765_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.stemcr.2013.11.009","article-title":"Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts","volume":"2","author":"Liu","year":"2014","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.bbrc.2024.150765_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ccr.2007.01.013","article-title":"Molecular definition of breast tumor heterogeneity","volume":"11","author":"Shipitsin","year":"2007","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.bbrc.2024.150765_bib39","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1158\/1078-0432.CCR-09-1532","article-title":"Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer","volume":"16","author":"Park","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbrc.2024.150765_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0126522","article-title":"Stemness of the hybrid epithelial\/mesenchymal state in breast cancer and its association with poor survival","volume":"10","author":"Grosse-Wilde","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bbrc.2024.150765_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ctrv.2013.09.008","article-title":"Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance","volume":"40","author":"Mallini","year":"2014","journal-title":"Cancer Treat Rev."},{"issue":"3","key":"10.1016\/j.bbrc.2024.150765_bib42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150765_bib43","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"issue":"3\u20134","key":"10.1016\/j.bbrc.2024.150765_bib44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10555-012-9377-5","article-title":"Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer","volume":"31","author":"Gunasinghe","year":"2012","journal-title":"Cancer Metastasis Rev."},{"issue":"8","key":"10.1016\/j.bbrc.2024.150765_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043752","article-title":"CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in epithelial to mesenchymal transition","volume":"7","author":"Imbert","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150765_bib46","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/bcr2215","article-title":"CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines","volume":"11","author":"Zabouo","year":"2009","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150765_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-017-0200-3","article-title":"CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion","volume":"15","author":"Ouhtit","year":"2017","journal-title":"Cell Commun. Signal."},{"issue":"8","key":"10.1016\/j.bbrc.2024.150765_bib48","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies - improving the management of early breast cancer: st GallenInternational expert consensus on the primary therapy of early breast cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann. Oncol."},{"issue":"24","key":"10.1016\/j.bbrc.2024.150765_bib49","doi-asserted-by":"crossref","first-page":"38294","DOI":"10.18632\/oncotarget.16203","article-title":"CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer","volume":"8","author":"Deng","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bbrc.2024.150765_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"issue":"March","key":"10.1016\/j.bbrc.2024.150765_bib51","first-page":"1","article-title":"NCOA4-mediated ferritinophagy: a potential link to neurodegeneration","volume":"13","author":"Del Rey","year":"2019","journal-title":"Front. Neurosci."},{"issue":"8","key":"10.1016\/j.bbrc.2024.150765_bib52","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.bbrc.2024.150765_bib53","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbrc.2018.02.097","article-title":"Lipid metabolism and lipophagy in cancer","volume":"504","author":"Maan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150765_bib54","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bbrc.2018.12.039","article-title":"Lipid storage and lipophagy regulates ferroptosis","volume":"508","author":"Bai","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150765_bib55","first-page":"1","article-title":"High RAS-related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma","volume":"12","author":"Liu","year":"2022","journal-title":"Sci. Rep."},{"issue":"49","key":"10.1016\/j.bbrc.2024.150765_bib56","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.bbrc.2024.150765_bib57","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/ijc.30834","article-title":"PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K\/AKT pathway activation","volume":"141","author":"Almozyan","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"21","key":"10.1016\/j.bbrc.2024.150765_bib58","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1158\/0008-5472.CAN-09-1067","article-title":"Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells","volume":"69","author":"Vitolo","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150765_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-023-01183-4","article-title":"Anoikis resistance\u2013\u2013protagonists of breast cancer cells survive and metastasize after ECM detachment","volume":"21","author":"Dai","year":"2023","journal-title":"Cell Commun. Signal."},{"issue":"10","key":"10.1016\/j.bbrc.2024.150765_bib60","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/jnci\/djk182","article-title":"Critical role for fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation","volume":"99","author":"Mawji","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.bbrc.2024.150765_bib61","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10495-013-0847-1","article-title":"Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-\u03baB","volume":"18","author":"Park","year":"2013","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150765_bib62","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.canlet.2013.01.021","article-title":"Entrapped doxorubicin nanoparticles for the treatment of metastatic anoikis-resistant cancer cells","volume":"332","author":"Lee","year":"2013","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150765_bib63","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12282-016-0738-8","article-title":"NF\u03baBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer","volume":"24","author":"Velaei","year":"2016","journal-title":"Breast Cancer"},{"issue":"February","key":"10.1016\/j.bbrc.2024.150765_bib64","first-page":"1","article-title":"The relationship between nuclear factor (NF)-\u03ba B family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bbrc.2024.150765_bib65","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1158\/1078-0432.CCR-03-0484","article-title":"Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer","volume":"10","author":"Pandya","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbrc.2024.150765_bib66","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1593\/neo.11260","article-title":"Kr\u00fcppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer","volume":"13","author":"Yori","year":"2011","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.bbrc.2024.150765_bib67","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12282-016-0708-1","article-title":"KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer","volume":"24","author":"Nagata","year":"2017","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150765_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-020-01305-7","article-title":"KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene","volume":"22","author":"Roberts","year":"2020","journal-title":"Breast Cancer Res."},{"issue":"9","key":"10.1016\/j.bbrc.2024.150765_bib69","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41568-021-00367-9","article-title":"MYC protein interactors in gene transcription and cancer","volume":"21","author":"Lourenco","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150765_bib70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene \u2014 the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24013019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24013019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T14:33:26Z","timestamp":1732631606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24013019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":70,"alternative-id":["S0006291X24013019"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150765","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standard chemotherapy impacts on in vitro cellular heterogeneity in spheroids enriched with cancer stem cells (CSCs) derived from triple-negative breast cancer cell line","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150765"}}